ResearcherRWTH Aachen UniversityActive in the last 2 years

Jennifer R. Kosinski

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-2213-0224; OpenAlex author ID A5080665425. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration. Co-author DOI 10.1002/1878-0261.13609 ↗
Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer. Co-author DOI 10.3390/cancers15030683 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sophia Villwock · 2 shared papers, 2023–2024 · strength 0.36
- Paper Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene S… DOI 10.3390/cancers15030683 ↗
- Paper ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and… DOI 10.1002/1878-0261.13609 ↗
Maximilian Hauschulz · 2 shared papers, 2023–2024 · strength 0.36
- Paper Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene S… DOI 10.3390/cancers15030683 ↗
- Paper ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and… DOI 10.1002/1878-0261.13609 ↗
Lara Rosaline Heij · 2 shared papers, 2023–2024 · strength 0.36
- Paper Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene S… DOI 10.3390/cancers15030683 ↗
- Paper ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and… DOI 10.1002/1878-0261.13609 ↗
Edgar Dahl · 2 shared papers, 2023–2024 · strength 0.36
- Paper Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene S… DOI 10.3390/cancers15030683 ↗
- Paper ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and… DOI 10.1002/1878-0261.13609 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.